Vimarsana
Biggest News Aggregation in the World

Page 25 - Pharma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Group Today - Breaking & Trending Today

ProPharma Group Launches Revolutionary New Operating Model To Deliver Life-Saving Drugs, Medical Devices And Diagnostics To Market Faster - Vimarsana News

ProPharma Group Launches Revolutionary New Operating Model To Deliver Life-Saving Drugs, Medical Devices And Diagnostics To Market Faster

RALEIGH, NC (PRWEB) January 09, 2023 -- ProPharma Group – the end-to-end, global provider of regulatory, clinical and compliance services for the

Source: prweb.com
Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong - Vimarsana News

Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit "Named Patients" in Hong Kong

HONG KONG, Jan. 9, 2023 /PRNewswire/ -- Luye Pharma's Innovative Anti-Cancer Therapy Lurbinectedin to Benefit

Antibiotics market to grow by 5.11% Y-O-Y from 2022 to 2023: Rising prevalence of infectious diseases will drive growth - Vimarsana News

Antibiotics market to grow by 5.11% Y-O-Y from 2022 to 2023: Rising prevalence of infectious diseases will drive growth

/PRNewswire/ -- Antibiotics market insights - Vendors: 15+, Including Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings...

JAMP Pharma Group receives Health Canada approval for PrJAMP Sitagliptin, a new generic alternative for the treatment of type 2 diabetes - Vimarsana News

JAMP Pharma Group receives Health Canada approval for PrJAMP Sitagliptin, a new generic alternative for the treatment of type 2 diabetes

The JAMP Pharma Group has received authorization to market Sitagliptin, offering a more affordable alternative to the reference product Januvia® (marketed by...

Year In Review: Top Biosimilars-Related Regulatory Developments Of 2022 - Life Sciences, Biotechnology & Nanotechnology - Vimarsana News

Year In Review: Top Biosimilars-Related Regulatory Developments Of 2022 - Life Sciences, Biotechnology & Nanotechnology

In July, we reported that Katherine Vidal, the Undersecretary of Commerce for Intellectual Property and Director of the USPTO, published a letter summarizing several initiatives...

Source: mondaq.com